Gotham Asset Management’s Supernus Pharmaceuticals SUPN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$555K Sell
17,623
-13,060
-43% -$412K ﹤0.01% 1299
2025
Q1
$1M Sell
30,683
-8,529
-22% -$279K 0.01% 1007
2024
Q4
$1.42M Buy
39,212
+1,419
+4% +$51.3K 0.01% 807
2024
Q3
$1.18M Buy
37,793
+26,742
+242% +$834K 0.01% 879
2024
Q2
$296K Buy
11,051
+4,046
+58% +$108K ﹤0.01% 1231
2024
Q1
$239K Buy
+7,005
New +$239K ﹤0.01% 1248
2023
Q3
Sell
-8,791
Closed -$264K 1408
2023
Q2
$264K Buy
+8,791
New +$264K 0.01% 1158
2022
Q2
Sell
-10,264
Closed -$332K 1247
2022
Q1
$332K Sell
10,264
-1,010
-9% -$32.7K 0.01% 921
2021
Q4
$329K Buy
11,274
+1,097
+11% +$32K 0.01% 925
2021
Q3
$271K Buy
+10,177
New +$271K 0.01% 873
2020
Q3
Sell
-10,812
Closed -$257K 1130
2020
Q2
$257K Sell
10,812
-34,167
-76% -$812K 0.01% 896
2020
Q1
$809K Sell
44,979
-37,468
-45% -$674K 0.02% 608
2019
Q4
$1.96M Sell
82,447
-21,103
-20% -$501K 0.04% 476
2019
Q3
$2.85M Buy
103,550
+4,477
+5% +$123K 0.05% 391
2019
Q2
$3.28M Buy
99,073
+14,808
+18% +$490K 0.05% 404
2019
Q1
$2.95M Buy
84,265
+44,913
+114% +$1.57M 0.04% 433
2018
Q4
$1.31M Buy
39,352
+31,287
+388% +$1.04M 0.02% 578
2018
Q3
$406K Buy
8,065
+1,689
+26% +$85K 0.01% 775
2018
Q2
$382K Sell
6,376
-26,405
-81% -$1.58M 0.01% 735
2018
Q1
$1.5M Sell
32,781
-106,816
-77% -$4.89M 0.02% 547
2017
Q4
$5.56M Sell
139,597
-28,939
-17% -$1.15M 0.08% 337
2017
Q3
$6.74M Buy
168,536
+144,155
+591% +$5.77M 0.1% 305
2017
Q2
$1.05M Sell
24,381
-77,620
-76% -$3.35M 0.01% 633
2017
Q1
$3.19M Buy
+102,001
New +$3.19M 0.04% 474
2016
Q3
Sell
-12,455
Closed -$254K 1037
2016
Q2
$254K Sell
12,455
-5,097
-29% -$104K ﹤0.01% 843
2016
Q1
$268K Sell
17,552
-16,256
-48% -$248K ﹤0.01% 861
2015
Q4
$454K Sell
33,808
-5,334
-14% -$71.6K ﹤0.01% 707
2015
Q3
$549K Sell
39,142
-49,125
-56% -$689K 0.01% 710
2015
Q2
$1.5M Buy
88,267
+46,581
+112% +$791K 0.01% 578
2015
Q1
$504K Buy
+41,686
New +$504K ﹤0.01% 693